|Day Low/High||32.49 / 33.03|
|52 Wk Low/High||30.23 / 36.74|
Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, announces the publication of a new research paper showing how a comprehensive ulcer prevention programme which included the use of...
The $1 billion transaction could inspire other medical device companies and private equity firms to bend over backwards for spinal device assets.
The hefty premium Zimmer Biomet is paying in the $1 billion deal for the spine company suggests the target's management followed a competitive process.
The medical device company is spending $350 million for the gynecology business of Smith & Nephew, and has agreed to invest in an Israeli spinal robotics company.
The embattled pharmaceutical company's move to bring in additional directors and file an overdue financial report did little to appease the markets.
Medical device company Stryker is paying $1.2 billion cash for defibrillator maker Physio-Control on the heels of spending $2.8 billion on disposable health care devices manufacturer Sage Products.
Kraft Heinz is the new king of the packaged-food aisle and ConforMis' shares can go higher, Cramer says.
A possible Greek deal and J&J, JPMorgan and Honeywell earnings, among many others, are on Cramer's calendar for next week.
European stocks rose on Tuesday after Greece offered concessions to its international creditors at an emergency summit, stoking hopes of a debt deal within the next two days.
TheStreet highlights 3 stocks pushing the health services industry higher today.